Bones and Joints: Osteoarthritis, Osteoporosis, Calcium, VitD, Phosphate Flashcards
Osteoarthritis
- epidemiology
- pathophsyiology, risk factors
- presentation
- investigations, diagnosis
Increases with age
- equal in male and females
- obesity
- past injury
Wear and tear of joint
Joint pain worse with use
Unilateral
DIP (Heberdens), PIP(Bouchards), CMC hip, knee - crepitus
No systemic upset
Generally a clinical diagnosis Xray can help -Loss of joint space -Osteophytes -Subchondral cysts -Subchondral sclerosis
Conservative
- weight loss, regular exercise, heat and ice
- simple analgesia, NSAIDs, capsaicin => joint injections
Joint replacement if prolonged, severe
Osteoporosis
- epidemiology
- pathophysiology, risk factors
Increased bone loss => low bone mass, reduced strength, increased fragility fracture risk
White, Asian Post menopausal women Past #/FHx of # Underweight BMI High alcohol, smoking, CS use Low VitD, Ca Inflammatory conditions Bone mets, cancer
Osteoporosis
- presentation
- investigations, diagnosis
Fragility fracture
- kyphosis, back pain - vertebral fracture
- low impact trauma
FRAX score - assess 10 year risk of fragility fracture
- low risk => reassure, lifestyle advice
- intermediate risk => DEXA needed for further info
- high risk => DEXA
Criteria for assessing fragility fracture risk
Female 65+
Male 75+
Younger patients with
- past fragility fracture, falls, FHx of hip fracture
- current/frequent CS
- underweight BMI
- Smoking
- Alcohol intake above weekly recommendations
Interpretation of DEXA scan results
T score - your measurement compared to the young reference population
T score
- -1+ = normal
- -1 - -2.5 = osteopenia
- U-2.5 = osteoporosis
Osteoporosis
-low risk management
Regular exercise
- outdoors => VitD
- strength training
Balanced diet
Smoking cessation
REduce alcohol
NO DRUG MANAGEMENT
Osteoporosis
-intermediate risk management
LOW RISK MANAGEMENT + DRUG MANAGEMENT if DEXA = U-2.5
If -2.5+ => low risk management
1st line - PO alendronate
-other options zolendronate, raloxifene, denosumab, teriparatide
Ca, VitD
- If only VitD low => prescribe VitD
- If Ca low => prescribe Ca + VitD
Osteoporosis
-high risk management
LOW RISK + DRUG if DEXA = U-2.5
If -2.5+ => modify risk factors, treat underlying conditions and repeat DEXA
1st line - PO alendronate
-other options zolendronate, raloxifene, denosumab, teriparatide
Ca, VitD
- If only VitD low => prescribe VitD
- If Ca low => prescribe Ca + VitD
Bisphosphonates
- MOA
- SE
Raloxifene
-MOA
Denosumab
- MOA
- SE
Teriparatide
-MOA
Bisphosphonate - Inhibit osteoclasts
- reflux => esophageal reaction
- MRONJ
- increased stress fracture risk
Raloxifene - SERM
Denosumab - inh RANKL => prevents osteoclast development
-infection, MRONJ, atypical fracture
Teriparatide - intermittent bone formation from anabolic action of PTH
-when stopped, use antiresorptive
Bone profile blood test
-what is tested
Routine bone investigations and why
Bone profile blood test
- Ca, PO4
- Albumin
- ALP
FBC, CRP - signs of myeloma, lymphoma U&E, LFTs - CKD, CLD TFT, PTH - hyperthyroidism, PTH VitD - deficiency Urine cortisol/dexmeth suppression- Cushings Urine and serum - myeloma Coeliac screen - malabsorption
Most common bone metastases and locations
MOST COMMON - Prostate
Breast
Lung
MOST COMMON - Spine Pelvis Ribs Skull LEAST COMMON - Long bones
Parathyroid hormone
-function
Active VitD
-function
PTH - increases serum Ca, decreases serum PO4
- Bone => Increase blood Ca
- Kidney => Increase Ca reabsorption from DCT, decreases PO4 reabsorption
- Intestine via kidney => VitD increases => increases GI Ca uptake
VitD - increases serum Ca AND PO4
- Bone => increase blood Ca
- Kidney => increase Ca and PO4 uptake
- GI => increase Ca uptake
Hypocalcemia
- causes
- presentation
- management
Causes
- Low VitD, PTH, Mg
- CKD
- Acute pancreatitis
Neuromuscular irritability - tingling of peripheries and mouth, cramps
Fatigue, anxiety
Acute - IV Ca gluconate + ECG monitoring
Definitive - address underlying cause
Osteomalacia
- presentation
- investigations and diagnosis
- management
Low Ca, PO4, VitD, high ALP => inadequate bone mineralization => soft bones
Diffuse joint, bone pain
Muscle weakness, difficulty walking
Easy fractures, bendy bones
VitD, Ca supplementation